AG-858
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AG-858, covering 2012-09-07 to 2012-09-07. Get the full timeline:
Most recent: Clinical Trial Update: AG-858 in Patients Who Are Cytogenetically Positive After Treatment With Gleevec™ [Phase 2]